- Home
- ALDX vs NB Comparison
ALDX vs NB Comparison
Compare ALDX & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- NB
- Stock Information
- Founded
- ALDX 2004
- NB 1987
- Country
- ALDX United States
- NB United States
- Employees
- ALDX N/A
- NB N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- NB Metal Mining
- Sector
- ALDX Health Care
- NB Basic Materials
- Exchange
- ALDX Nasdaq
- NB Nasdaq
- Market Cap
- ALDX 270.7M
- NB 231.0M
- IPO Year
- ALDX 2014
- NB N/A
- Fundamental
- Price
- ALDX $4.81
- NB $3.16
- Analyst Decision
- ALDX Strong Buy
- NB Strong Buy
- Analyst Count
- ALDX 2
- NB 2
- Target Price
- ALDX $9.50
- NB $4.50
- AVG Volume (30 Days)
- ALDX 1.2M
- NB 2.8M
- Earning Date
- ALDX 08-12-2025
- NB 09-12-2025
- Dividend Yield
- ALDX N/A
- NB N/A
- EPS Growth
- ALDX N/A
- NB N/A
- EPS
- ALDX N/A
- NB N/A
- Revenue
- ALDX N/A
- NB N/A
- Revenue This Year
- ALDX N/A
- NB N/A
- Revenue Next Year
- ALDX $29.89
- NB N/A
- P/E Ratio
- ALDX N/A
- NB N/A
- Revenue Growth
- ALDX N/A
- NB N/A
- 52 Week Low
- ALDX $1.14
- NB $1.27
- 52 Week High
- ALDX $7.20
- NB $4.36
- Technical
- Relative Strength Index (RSI)
- ALDX 53.97
- NB 53.83
- Support Level
- ALDX $5.21
- NB $2.64
- Resistance Level
- ALDX $5.35
- NB $3.41
- Average True Range (ATR)
- ALDX 0.33
- NB 0.29
- MACD
- ALDX -0.12
- NB -0.06
- Stochastic Oscillator
- ALDX 40.70
- NB 30.23
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.